Search research articles
Contact Us
Filters
Showing results (21-30 of 36) with videos related to
Page
of 4
Sort By:
Diabetes Research and Clinical Practice
|
November 2, 2001
Prevalence of diabetes, obesity and hypertension in a Turkish population (Trabzon city)
C Erem, R Yildiz, H Kavgaci, et al.
Acta Cardiologica
|
June 23, 1999
Plasma lipoprotein (a) concentrations in hypothyroid, euthyroid and hyperthyroid subjects
C Erem, O Değer, M Bostan, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association
|
April 9, 2014
Comparison of effects of gliclazide, metformin and pioglitazone monotherapies on glycemic control and cardiovascular risk factors in patients with newly diagnosed uncontrolled type 2 diabetes mellitus
C Erem, H M Ozbas, I Nuhoglu, et al.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity
|
January 16, 2004
Effect of low-dose metoprolol in combination with sibutramine therapy in normotensive obese patients: a randomized controlled study
H O Ersoz, K Ukinc, M Baykan, et al.
Clinical Chemistry and Laboratory Medicine
|
May 9, 2001
The effects of impaired trace element status on polymorphonuclear leukocyte activation in the development of vascular complications in type 2 diabetes mellitus
S C Karahan, O Değer, A Orem, et al.
Journal of Endocrinological Investigation
|
May 5, 2009
Blood coagulation and fibrinolysis in patients with Cushing's syndrome: increased plasminogen activator inhibitor-1, decreased tissue factor pathway inhibitor, and unchanged thrombin-activatable fibrinolysis inhibitor levels
C Erem, I Nuhoglu, M Yilmaz, et al.
Journal of Endocrinological Investigation
|
August 25, 2005
Pheochromocytoma combined with pre-clinical Cushing's syndrome in the same adrenal gland
C Erem, A Hacihasanoglu, H O Ersöz, et al.
Diabetes Research and Clinical Practice
|
September 5, 2001
Decreased nitric oxide end-products and its relationship with high density lipoprotein and oxidative stress in people with type 2 diabetes without complications
B Vanizor, A Orem, S C Karahan, et al.
Endocrine
|
July 16, 2014
Atrial conduction times and left atrium mechanical functions in patients with active acromegaly
A Ilter, A Kırış, Ş Kaplan, et al.
Journal of Endocrinological Investigation
|
February 27, 2003
Clinical laboratory findings and results of therapy in 55 patients with Cushing's syndrome
C Erem, E Algün, N Ozbey, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 36) with videos related to
Sort By:
Page
of 4
Diabetes Research and Clinical Practice
|
November 2, 2001
Prevalence of diabetes, obesity and hypertension in a Turkish population (Trabzon city)
C Erem, R Yildiz, H Kavgaci, et al.
Acta Cardiologica
|
June 23, 1999
Plasma lipoprotein (a) concentrations in hypothyroid, euthyroid and hyperthyroid subjects
C Erem, O Değer, M Bostan, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association
|
April 9, 2014
Comparison of effects of gliclazide, metformin and pioglitazone monotherapies on glycemic control and cardiovascular risk factors in patients with newly diagnosed uncontrolled type 2 diabetes mellitus
C Erem, H M Ozbas, I Nuhoglu, et al.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity
|
January 16, 2004
Effect of low-dose metoprolol in combination with sibutramine therapy in normotensive obese patients: a randomized controlled study
H O Ersoz, K Ukinc, M Baykan, et al.
Clinical Chemistry and Laboratory Medicine
|
May 9, 2001
The effects of impaired trace element status on polymorphonuclear leukocyte activation in the development of vascular complications in type 2 diabetes mellitus
S C Karahan, O Değer, A Orem, et al.
Journal of Endocrinological Investigation
|
May 5, 2009
Blood coagulation and fibrinolysis in patients with Cushing's syndrome: increased plasminogen activator inhibitor-1, decreased tissue factor pathway inhibitor, and unchanged thrombin-activatable fibrinolysis inhibitor levels
C Erem, I Nuhoglu, M Yilmaz, et al.
Journal of Endocrinological Investigation
|
August 25, 2005
Pheochromocytoma combined with pre-clinical Cushing's syndrome in the same adrenal gland
C Erem, A Hacihasanoglu, H O Ersöz, et al.
Diabetes Research and Clinical Practice
|
September 5, 2001
Decreased nitric oxide end-products and its relationship with high density lipoprotein and oxidative stress in people with type 2 diabetes without complications
B Vanizor, A Orem, S C Karahan, et al.
Endocrine
|
July 16, 2014
Atrial conduction times and left atrium mechanical functions in patients with active acromegaly
A Ilter, A Kırış, Ş Kaplan, et al.
Journal of Endocrinological Investigation
|
February 27, 2003
Clinical laboratory findings and results of therapy in 55 patients with Cushing's syndrome
C Erem, E Algün, N Ozbey, et al.
Page
of 4